GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Green Planet Bioengineering Co Ltd (OTCPK:GPLB) » Definitions » Debt-to-EBITDA

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Debt-to-EBITDA : 0.00 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Green Planet Bioengineering Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Green Planet Bioengineering Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Green Planet Bioengineering Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Green Planet Bioengineering Co's annualized EBITDA for the quarter that ended in Mar. 2024 was $-0.02 Mil. Green Planet Bioengineering Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Green Planet Bioengineering Co's Debt-to-EBITDA or its related term are showing as below:

GPLB's Debt-to-EBITDA is not ranked *
in the Diversified Financial Services industry.
Industry Median: 5.42
* Ranked among companies with meaningful Debt-to-EBITDA only.

Green Planet Bioengineering Co Debt-to-EBITDA Historical Data

The historical data trend for Green Planet Bioengineering Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Planet Bioengineering Co Debt-to-EBITDA Chart

Green Planet Bioengineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Green Planet Bioengineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Green Planet Bioengineering Co's Debt-to-EBITDA

For the Shell Companies subindustry, Green Planet Bioengineering Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Planet Bioengineering Co's Debt-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Green Planet Bioengineering Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Green Planet Bioengineering Co's Debt-to-EBITDA falls into.



Green Planet Bioengineering Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Green Planet Bioengineering Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -0.047
=0.00

Green Planet Bioengineering Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -0.024
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Green Planet Bioengineering Co  (OTCPK:GPLB) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Green Planet Bioengineering Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Green Planet Bioengineering Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Planet Bioengineering Co (Green Planet Bioengineering Co) Business Description

Traded in Other Exchanges
N/A
Address
20807 Biscayne Boulevard, Suite 203, Aventura, FL, USA, 33180
Green Planet Bioengineering Co Ltd is a shell company.
Executives
Shanyan Ou director, officer: VP of Sales 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Jian Chen director, officer: Chief Scientist 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Jianrong Zheng director 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Zhao 10 percent owner, officer: CHIEF EXECUTIVE OFFICER 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Yan Zhen 10 percent owner 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Cris Neely director, 10 percent owner, officer: President 18851 NE 29TH AVENUE, SUITE 700, AVENTURA CA 33180
Mondo Management Corp. 10 percent owner 61 BROADWAY, NEW YORK NY 10006
Gregory Sichenzia director, 10 percent owner SICHENZIA ROSS FRIEDMAN FERENCE LLP, 1065 AVENUE OF THE AMERICAS, 21ST FLOOR, NEW YORK NY 10018
Darrin M Ocasio director, 10 percent owner, officer: President C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006
Michael H Ference director, 10 percent owner, officer: Secretary C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Headlines

No Headlines